Amgen Quarterly Balance Sheet
NASDAQ: AMGNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Amgen financial position
As of Jun 30, 2026, Amgen reported total assets of $95.64 billion, up 8.8% from a year earlier against total liabilities of $83.95 billion. Shareholders' equity stood at $11.69 billion, or 12.2% of assets. The company held $13.99 billion in cash and equivalents against $57.30 billion of debt, a net debt position of $43.31 billion.
The current ratio (current assets divided by current liabilities) was 1.37, meaning short-term assets cover obligations due within a year. Debt-to-equity was 4.90.
Summary generated from market data by MetaCap's automated system. Methodology
Amgen balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 13.99B | 12.04B | 9.13B | 9.45B | 8.03B | 8.81B | 11.97B | 9.01B | 9.30B | 9.71B | 10.94B | 34.74B |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | — | 0 | 0 |
| Receivables | 10.23B | 9.14B | 9.57B | 8.49B | 8.70B | 8.13B | 6.78B | 7.32B | 6.93B | 6.78B | 7.27B | 6.14B |
| Inventory | 6.22B | 6.19B | 6.22B | 6.35B | 6.58B | 6.73B | 7.00B | 7.36B | 8.00B | 8.72B | 9.52B | 5.03B |
| Total Current Assets | 34.96B | 31.48B | 29.06B | 27.89B | 26.73B | 26.93B | 29.03B | 26.77B | 27.21B | 28.03B | 30.33B | 48.48B |
| Property, Plant & Equipment | 8.55B | 8.22B | 7.91B | 7.22B | 6.86B | 6.68B | 6.54B | 6.16B | 6.10B | 6.00B | 5.94B | 5.56B |
| Goodwill | 18.67B | 18.67B | 18.68B | 18.68B | 18.67B | 18.64B | 18.64B | 18.66B | 18.62B | 18.57B | 18.63B | 15.51B |
| Intangible Assets | 20.49B | 21.38B | 22.28B | 23.14B | 24.61B | 25.72B | 27.70B | 28.92B | 30.17B | 31.37B | 32.64B | 13.15B |
| Total Assets | 95.64B | 92.50B | 90.59B | 90.14B | 87.90B | 89.37B | 91.84B | 90.88B | 90.91B | 92.98B | 97.15B | 90.53B |
| Accounts Payable | 2.87B | 2.94B | 2.37B | 2.84B | 3.01B | 2.41B | 1.91B | 2.15B | 2.27B | 1.63B | 1.59B | 1.36B |
| Short-Term Debt | 5.45B | 5.44B | 4.60B | 2.15B | 2.44B | 3.37B | 3.55B | 3.54B | 5.53B | 3.96B | 1.44B | 1.43B |
| Total Current Liabilities | 25.50B | 24.95B | 25.49B | 21.79B | 20.48B | 23.01B | 23.10B | 20.31B | 21.52B | 19.71B | 18.39B | 16.95B |
| Long-Term Debt | 51.86B | 51.89B | 50.01B | 52.43B | 53.76B | 54.01B | 56.55B | 56.85B | 57.12B | 60.06B | 63.17B | 59.04B |
| Total Liabilities | 83.95B | 83.31B | 81.93B | 80.52B | 80.47B | 83.16B | 85.96B | 83.36B | 84.98B | 87.96B | 90.92B | 82.88B |
| Shareholders' Equity | 11.69B | 9.19B | 8.66B | 9.62B | 7.43B | 6.21B | 5.88B | 7.53B | 5.92B | 5.02B | 6.23B | 7.66B |
| Retained Earnings | -22.27B | -24.65B | -25.11B | -23.80B | -25.71B | -27.14B | -27.59B | -25.53B | -27.12B | -27.87B | -26.55B | -24.97B |
| Total Debt | 57.30B | 57.32B | 54.60B | 54.59B | 56.20B | 57.38B | 60.10B | 60.40B | 62.65B | 64.02B | 64.61B | 60.47B |
| Net Cash (Debt) | -43.31B | -45.28B | -45.48B | -45.14B | -48.18B | -48.57B | -48.13B | -51.39B | -53.34B | -54.31B | -53.67B | -25.73B |
| Shares Outstanding | 540.60M | 539.70M | 538.80M | 538.50M | 538.30M | 537.70M | 536.90M | 537.50M | 537.20M | 536.40M | 535.40M | 535.10M |
This table shows 12 quarterly periods of Amgen's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow AMGN's reporting calendar. What is a balance sheet?